Fundraising Fox

Longevity Series A Investors & VC Firms

155 firms in this list, with a median first check of $450K. 39 of them lead rounds. Generated from verified public data and updated continuously.

Casdin Capital
New YorkSeed–Series C
39 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
42 people
Type One Ventures
Los AngelesPre-Seed–Late Stage$100K – $5M
22 people
LongeVC
Washington D.C.Pre-Seed–Series A
39 people
JAZZ Venture Partners
San FranciscoSeed–Late Stage$100K – $20M
19 people
Deepbridge Capital
ChesterSeed–Growth
18 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
iSelect Fund
St. LouisSeed–Late Stage$250K – $2M
12 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
29 people
HealthCap
StockholmSeed–Growth
30 people
ClavystBio
SingaporeSeed–Series A
33 people
DOMiNO Ventures
AmsterdamSeed–Series B$220K – $1.1M
30 people
aMoon
Ra'ananaSeed–Late Stage
23 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
18 people
Digitalis Ventures
New YorkSeed–Late Stage$100K – $10M
18 people
Modi Ventures
HoustonSeed–Series A
20 people
BioAdvance
ConshohockenPre-Seed–Late Stage$500K – $1.5M
15 people
K2 HealthVentures
BostonSeries A–Late Stage$10M – $100M
22 people
Hiro Capital
LondonSeries A–Late Stage
23 people
Alta Partners
JacksonSeed–Growth$1M – $12M
9 people
Apollo Health Ventures
BerlinSeed–Series A
29 people
Primetime Partners
New YorkSeed–Series A$250K – $1M
13 people
Pontifax Venture Capital
HerzeliyaPre-Seed–Late Stage$6.3M – $128M
8 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.